Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Capital Expenditures (2016 - 2025)

cbdMD's Capital Expenditures history spans 10 years, with the latest figure at $164802.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures changed 0.25% year-over-year to $164802.0; the TTM value through Dec 2025 reached $184587.0, up 8.73%, while the annual FY2025 figure was $184172.0, 3.08% down from the prior year.
  • Capital Expenditures for Q4 2025 was $164802.0 at cbdMD, up from $2804.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $231030.0 in Q4 2021 and bottomed at -$102390.0 in Q1 2023.
  • The 5-year median for Capital Expenditures is $102389.0 (2023), against an average of $93365.1.
  • The largest annual shift saw Capital Expenditures skyrocketed 643.93% in 2022 before it plummeted 171.72% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $231030.0 in 2021, then dropped by 23.23% to $177370.0 in 2022, then grew by 4.1% to $184635.0 in 2023, then fell by 10.97% to $164387.0 in 2024, then rose by 0.25% to $164802.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Capital Expenditures are $164802.0 (Q4 2025), $2804.0 (Q3 2025), and $1475.0 (Q2 2025).